Literature DB >> 17197561

A strong genetic determinant of hyperoxia-related retinal degeneration on mouse chromosome 6.

Zeljka Smit-McBride1, Sharon L Oltjen, Matthew M Lavail, Leonard M Hjelmeland.   

Abstract

PURPOSE: Hyperoxia-related retinal degeneration (HRRD) is a model system in the mouse in which elevated oxygen levels are used to induce retinal degeneration. The hypothesis for the present study was that strain differences in HRRD susceptibility are due to allelic variants of one or more genes in the mouse genome whose human orthologues should be important targets for research and drug development.
METHODS: C57BL/6J, A/J, or B.A-Chr6 mice were exposed to 75% oxygen (hyperoxia) or room air for 14 days. After death, one eye was fixed and processed for outer nuclear layer (ONL) thickness measurements. The retina and RPE/choroid were separately dissected from the fellow eye and processed for microarray analysis. Single nucleotide polymorphism (SNP) analysis for transcribed sequences from the C57BL/6J and A/J genomes was conducted using the NIH genome site.
RESULTS: C57BL/6J mice developed a significant retinal degeneration in the inferior hemisphere after 14 days of hyperoxia. Under identical conditions, A/J mice exhibited only minor changes. A significant genetic effect was located on chromosome 6. SNP analysis of known transcribed sequences on chromosome 6 combined with microarray expression analysis yielded 33 candidate genes.
CONCLUSIONS: A significant genetic effect of susceptibility to HRRD is located on chromosome 6. In silico analysis of transcribed sequences results in a fairly small number of candidate genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197561     DOI: 10.1167/iovs.06-0854

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Differential gene expression in mouse retina related to regional differences in vulnerability to hyperoxia.

Authors:  Yuan Zhu; Riccardo Natoli; Krisztina Valter; Jonathan Stone
Journal:  Mol Vis       Date:  2010-04-28       Impact factor: 2.367

2.  Localization of complement factor H gene expression and protein distribution in the mouse outer retina.

Authors:  Zeljka Smit-McBride; Sharon L Oltjen; Roxana A Radu; Jason Estep; Anthony T Nguyen; Qizhi Gong; Leonard M Hjelmeland
Journal:  Mol Vis       Date:  2015-02-05       Impact factor: 2.367

3.  D-cis-Diltiazem Can Produce Oxidative Stress in Healthy Depolarized Rods In Vivo.

Authors:  Bruce A Berkowitz; Robert H Podolsky; Benjamin Farrell; Hojun Lee; Christopher Trepanier; Ali M Berri; Kristin Dernay; Emma Graffice; Fatema Shafie-Khorassani; Timothy S Kern; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.925

4.  Evolving Patterns of Hyperfluorescent Fundus Autofluorescence Accompany Retinal Atrophy in the Rat and Mimic Atrophic Age-Related Macular Degeneration.

Authors:  Natalie Pankova; David Sung Hyeon Baek; Xu Zhao; Hai Wang; Matthew-Mina Reyad; Huiyuan Liang; Rahul Joshi; Shelley Romayne Boyd
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

5.  Gene regulation induced in the C57BL/6J mouse retina by hyperoxia: a temporal microarray study.

Authors:  Riccardo Natoli; Jan Provis; Krisztina Valter; Jonathan Stone
Journal:  Mol Vis       Date:  2008-10-31       Impact factor: 2.367

6.  Age-dependent increase in miRNA-34a expression in the posterior pole of the mouse eye.

Authors:  Zeljka Smit-McBride; Krisztina I Forward; Anthony T Nguyen; Matthew H Bordbari; Sharon L Oltjen; Leonard M Hjelmeland
Journal:  Mol Vis       Date:  2014-11-05       Impact factor: 2.367

7.  Comparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone Acetonide.

Authors:  Zeljka Smit-McBride; Elad Moisseiev; Sara P Modjtahedi; David G Telander; Leonard M Hjelmeland; Lawrence S Morse
Journal:  J Ophthalmol       Date:  2016-06-27       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.